Go back to News
NEWS
GA_P advises Vista Equity Partners on €2.425m acquisition of Duck Creek
GA_P has advised investment fund Vista Equity Partners on the Spanish leg of the acquisition of Duck Creek Technologies (NASDAQ: DCT) to delist it from the stock exchange.
Vista Equity Partners has reached an agreement with technology company Duck Creek Technologies to acquire it for a total of $2.6 billion (€2.425 billion) in cash. The deal is expected to close in the second quarter of 2023, subject to the satisfaction of certain conditions customary in such transactions, after which the entity will be delisted.
Duck Creek specialises in providing customer management software products to insurance companies and broker-dealers.
Vista Equity Partners is a leading global investment fund investing in enterprise software, data and technology companies.
They advised on the transaction: Alex Pujol, partner of Commercial, Andrea Esbrí, senior associate of Commercial, Mònica Martells, associate of Commercial, and Anna Viladás and Paula Ruiz Cotorro from Industrial Property, Intellectual Property and Technology.
Vista Equity Partners has reached an agreement with technology company Duck Creek Technologies to acquire it for a total of $2.6 billion (€2.425 billion) in cash. The deal is expected to close in the second quarter of 2023, subject to the satisfaction of certain conditions customary in such transactions, after which the entity will be delisted.
Duck Creek specialises in providing customer management software products to insurance companies and broker-dealers.
Vista Equity Partners is a leading global investment fund investing in enterprise software, data and technology companies.
They advised on the transaction: Alex Pujol, partner of Commercial, Andrea Esbrí, senior associate of Commercial, Mònica Martells, associate of Commercial, and Anna Viladás and Paula Ruiz Cotorro from Industrial Property, Intellectual Property and Technology.
Lawyer mentioned
Andrea Esbrí – Senior associate
Category
Deal
Press contact

Sandra Cuesta
Director of Business Development, Marketing and Communications

Sandra Cuesta
Director of Business Development, Marketing and Communications
More information about
Gómez-Acebo & Pombo
PUBLICATION
One week ago
Contractual termination by mutual abandonment not claimed by any party?
The risks of applying the doctrine according to which a contract is deemed withdrawn from if neither party to the same appears to want it. Not only is this solution likely to be inconsistent with the parties' claims, but it also wrongly rules out other civil law options the parties could pursue upon dismissal of the action for declaration of termination.
PUBLICATION
25 Sep, 2025
Pharma & Healthcare No. 45
The newsletter covers the main developments in Pharma & Healthcare legislation and case law.
PUBLICATION
19 Sep, 2025
The Unified Patent Court grants interim relief regarding a European patent validated in Spain: critical considerations
The Decision of the Hamburg Local Division of the Court of First Instance of the Unified Patent Court dated 14 August 2025 grants interim relief because it claims jurisdiction to hear the substance of the matter (both the infringement of the unitary patent in the States party to the UPC Agreement and the Spanish validation of the European patent on which the unitary patent is based). To this end, the court offers a series of observations on its international jurisdiction, not all of which are accurate.
PUBLICATION
01 Sep, 2025
Denomination of a plant variety and descriptive use of a third-party trade mark
There is no doubt that the registered name of a plant variety may be used by anyone who markets plant material of that variety. However, in this specific case, the Supreme Court's statement that “the term ‘Persimmon’ was used by the defendant to identify a specific variety of caqui” is noteworthy.
PUBLICATION
05 Aug, 2025
Automotive and Sustainable Mobility No. 27
Summary of legislative and jurisprudential developments relating to the automotive sector.
PUBLICATION
30 Jul, 2025
Absolute prohibitions on pharmacy advertising are contrary to EU law
In its judgment of 19 June 2025 (European Commission v Republic of Poland, C‑200/24, ECLI:EU:C:2025:459), the Court of Justice has held that the introduction by national legislation of a total prohibition on advertising for pharmacies infringes European Union law.
PUBLICATION
29 Jul, 2025
The use of personal data to train artificial intelligence systems
The judgment of the Regional High Court (Oberlandesgericht) of Cologne of 23 May 2025 (15 UKl 2/25), in which the German court rejects the application for interim relief prohibiting the defendant from processing personal data published by consumers on Facebook and Instagram for the development and improvement of artificial intelligence systems, is analysed.
PUBLICATION
09 Jul, 2025
Once again on the obligations assumed by the signers of a "strong" comfort letter
PUBLICATION
02 Jul, 2025
Pharma & Healthcare No. 44
The newsletter covers the main developments in Pharma & Healthcare legislation and case law.